CONMED (CNMD *) Stock Overview
A medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
CNMD * Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
CONMED Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$720.00 |
| 52 Week High | US$819.40 |
| 52 Week Low | US$720.00 |
| Beta | 0.99 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -63.36% |
| 5 Year Change | -73.15% |
| Change since IPO | -56.52% |
Recent News & Updates
Recent updates
Shareholder Returns
| CNMD * | MX Medical Equipment | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how CNMD * performed against the MX Medical Equipment industry.
Return vs Market: Insufficient data to determine how CNMD * performed against the MX Market.
Price Volatility
| CNMD * volatility | |
|---|---|
| CNMD * Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: CNMD *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine CNMD *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1970 | 3,900 | Pat Beyer | www.conmed.com |
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name.
CONMED Corporation Fundamentals Summary
| CNMD * fundamental statistics | |
|---|---|
| Market cap | Mex$20.43b |
| Earnings (TTM) | Mex$816.03m |
| Revenue (TTM) | Mex$23.84b |
Is CNMD * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CNMD * income statement (TTM) | |
|---|---|
| Revenue | US$1.37b |
| Cost of Revenue | US$634.15m |
| Gross Profit | US$740.58m |
| Other Expenses | US$693.52m |
| Earnings | US$47.06m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Apr 29, 2026
| Earnings per share (EPS) | 1.56 |
| Gross Margin | 53.87% |
| Net Profit Margin | 3.42% |
| Debt/Equity Ratio | 80.7% |
How did CNMD * perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/20 02:11 |
| End of Day Share Price | 2026/01/21 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CONMED Corporation is covered by 15 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Travis Steed | Barclays |
| Travis Steed | BofA Global Research |
| Kristen Stewart | CL King & Associates, Inc. |